Search Results - "Calcutt, N"

Refine Results
  1. 1

    Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice by Jolivalt, C. G., Rodriguez, M., Wahren, J., Calcutt, N. A.

    Published in Diabetes, obesity & metabolism (01-08-2015)
    “…Aims To investigate the efficacy of a pegylated C‐peptide (Peg‐C‐peptide) against indices of peripheral neuropathy in a mouse model of type 1 diabetes and to…”
    Get full text
    Journal Article
  2. 2

    GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice by Jolivalt, C. G., Fineman, M., Deacon, C. F., Carr, R. D., Calcutt, N. A.

    Published in Diabetes, obesity & metabolism (01-11-2011)
    “…Aim: Glucagon‐like peptide‐1 (GLP‐1) is an incretin hormone that induces glucose‐dependent insulin secretion and may have neurotrophic properties. Our aim was…”
    Get full text
    Journal Article
  3. 3

    Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor by CALCUTT, N. A, FRESHWATER, J. D, MIZISIN, A. P

    Published in Diabetologia (01-04-2004)
    “…Sensory neuropathy in diabetic patients frequently presents itself as progressive loss of thermal perception, while some patients describe concurrent…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes by Jolivalt, C. G., Aghanoori, M. R., Navarro-Diaz, M. C., Han, M. M., Sanchez, G., Guernsey, L., Quach, D., Johe, K., Fernyhough, P., Calcutt, N. A.

    Published in Journal of diabetes research (04-07-2022)
    “…Aims. Mitochondrial dysfunction contributes to many forms of peripheral and central nervous system degeneration. Therapies that protect mitochondrial number…”
    Get full text
    Journal Article
  6. 6

    Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease by Jolivalt, C.G, Calcutt, N.A, Masliah, E

    Published in Neuroscience (27-01-2012)
    “…Abstract There is an increasing awareness that diabetes has an impact on the CNS and that diabetes is a risk factor for Alzheimer's disease (AD). Links between…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats by JOLIVALT, C. G, JIANG, Y, FRESHWATER, J. D, BARTOSZYK, G. D, CALCUTT, N. A

    Published in Diabetologia (01-11-2006)
    “…We investigated spinal and peripheral kappa opioid systems in diabetic rats. Dynorphin A, N-methyl-D-aspartate (NMDA) and kappa opioid receptor (KOR) were…”
    Get full text
    Journal Article
  13. 13

    Neuronal Nitric Oxide Synthase mRNA Upregulation in Rat Sensory Neurons after Spinal Nerve Ligation: Lack of a Role in Allodynia Development by Luo, Z. David, Chaplan, S. R, Scott, B. P, Cizkova, D, Calcutt, N. A, Yaksh, T. L

    Published in The Journal of neuroscience (01-11-1999)
    “…Pharmacological evidence suggests a functional role for spinal nitric oxide (NO) in the modulation of thermal and/or inflammatory hyperalgesia. To assess the…”
    Get full text
    Journal Article
  14. 14

    Spinal pharmacology of tactile allodynia in diabetic rats by Calcutt, Nigel A., Chaplan, Sandra R.

    Published in British journal of pharmacology (01-12-1997)
    “…1 Rats develop tactile allodynia to stimulation of the plantar surface of the hindpaw with von Frey filaments within days of the onset of…”
    Get full text
    Journal Article
  15. 15

    Gabapentin prevents hyperalgesia during the formalin test in diabetic rats by Ceseña, R.M, Calcutt, N.A

    Published in Neuroscience letters (05-03-1999)
    “…The anticonvulsant agent gabapentin exhibits antihyperalgesic properties in animal models of neuropathic pain. Diabetic rats display increased nocifensive…”
    Get full text
    Journal Article
  16. 16

    Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine by Calcutt, N A, Jorge, M C, Yaksh, T L, Chaplan, S R

    Published in Pain (Amsterdam) (01-12-1996)
    “…Rats developed tactile allodynia within days of the onset of diabetes and which persisted for up to 8 weeks. Allodynia was prevented by insulin therapy that…”
    Get more information
    Journal Article
  17. 17

    Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats by Calcutt, Nigel A, Stiller, Carl-Olav, Gustafsson, Henrik, Malmberg, Annika B

    Published in Brain research (21-02-2000)
    “…Pharmacologic studies implicate the involvement of substance P in spinal nociceptive processing during the formalin test. However, no direct measurement of the…”
    Get full text
    Journal Article
  18. 18

    Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats by KALICHMAN, M. W, CALCUTT, N. A

    Published in Anesthesiology (Philadelphia) (01-11-1992)
    “…Patients with diabetes may have peripheral neuropathy, which may have clinical implications for the use of regional nerve block. The effects of local…”
    Get full text
    Journal Article
  19. 19

    Prosaptide prevents paclitaxel neurotoxicity by Campana, W M, Eskeland, N, Calcutt, N A, Misasi, R, Myers, R R, O'Brien, J S

    Published in Neurotoxicology (Park Forest South) (01-04-1998)
    “…Paclitaxel (Taxol), a chemotherapeutic agent used to treat breast and ovarian tumors, has been reported to induce a predominantly sensory neuropathy…”
    Get more information
    Journal Article
  20. 20

    Regulation of Expression of the Sensory Neuron-Specific Sodium Channel SNS in Inflammatory and Neuropathic Pain by Okuse, Kenji, Chaplan, Sandra R., McMahon, Stephen B., Luo, Z.David, Calcutt, Nigel A., Scott, Brian P., Akopian, Armen N., Wood, John N.

    “…Increased voltage-gated sodium channel activity may contribute to the hyperexcitability of sensory neurons in inflammatory and neuropathic pain states. We…”
    Get full text
    Journal Article